Disease and Therapy Review: Asthma

Disease and Therapy Review: Asthma

The Asthma Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, an overview of short-acting medications for quick relief of symptoms, and a review of treatments used to provide long-term control. Dosing information and treatment costs are provided for a wide range of products. General information is included on the size of the asthma market, and on sales of major products. 
 



Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  

I. Overview

II. Incidence and Prevalence

Incidence Table: (US, Italy)

Prevalence Table: (US, Canada, UK, France, Germany, Italy, Spain, Japan, China, India, Worldwide)

III. TREATMENT

Long-term Control Medications

Quick Relief Medications

Approach to Treatment of Asthma Exacerbations

Treatment Rates

IV. DOSING AND TREATMENT COSTS

V. MARKET SIZE

VI. COMMENTS

VII. References/Resources